Log In
Print this Print this

Tadekinig alfa (IL-18BP)

  Manage Alerts
Collapse Summary General Information
Company AB2 Bio Ltd.
DescriptionRecombinant human binding protein with high affinity for IL-18
Molecular Target Interleukin-18 (IL-18)
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today